166 related articles for article (PubMed ID: 35379108)
21. A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics.
Mizzi C; Dalabira E; Kumuthini J; Dzimiri N; Balogh I; Başak N; Böhm R; Borg J; Borgiani P; Bozina N; Bruckmueller H; Burzynska B; Carracedo A; Cascorbi I; Deltas C; Dolzan V; Fenech A; Grech G; Kasiulevicius V; Kádaši Ľ; Kučinskas V; Khusnutdinova E; Loukas YL; Macek M; Makukh H; Mathijssen R; Mitropoulos K; Mitropoulou C; Novelli G; Papantoni I; Pavlovic S; Saglio G; Setric J; Stojiljkovic M; Stubbs AP; Squassina A; Torres M; Turnovec M; van Schaik RH; Voskarides K; Wakil SM; Werk A; Del Zompo M; Zukic B; Katsila T; Lee MT; Motsinger-Rief A; Mc Leod HL; van der Spek PJ; Patrinos GP
PLoS One; 2016; 11(9):e0162866. PubMed ID: 27636550
[TBL] [Abstract][Full Text] [Related]
22. Pharmacogenomics in the era of next generation sequencing - from byte to bedside.
Russell LE; Zhou Y; Almousa AA; Sodhi JK; Nwabufo CK; Lauschke VM
Drug Metab Rev; 2021 May; 53(2):253-278. PubMed ID: 33820459
[TBL] [Abstract][Full Text] [Related]
23. Actionable pharmacogenetic variants in Hong Kong Chinese exome sequencing data and projected prescription impact in the Hong Kong population.
Yu MHC; Chan MCY; Chung CCY; Li AWT; Yip CYW; Mak CCY; Chau JFT; Lee M; Fung JLF; Tsang MHY; Chan JCK; Wong WHS; Yang J; Chui WCM; Chung PHY; Yang W; Lee SL; Chan GCF; Tam PKH; Lau YL; Tang CSM; Yeung KS; Chung BHY
PLoS Genet; 2021 Feb; 17(2):e1009323. PubMed ID: 33600428
[TBL] [Abstract][Full Text] [Related]
24. Real-World Evaluation of Universal Germline Screening for Cancer Treatment-Relevant Pharmacogenes.
Hutchcraft ML; Lin N; Zhang S; Sears C; Zacholski K; Belcher EA; Durbin EB; Villano JL; Cavnar MJ; Arnold SM; Ueland FR; Kolesar JM
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572750
[TBL] [Abstract][Full Text] [Related]
25. Characterization of 137 Genomic DNA Reference Materials for 28 Pharmacogenetic Genes: A GeT-RM Collaborative Project.
Pratt VM; Everts RE; Aggarwal P; Beyer BN; Broeckel U; Epstein-Baak R; Hujsak P; Kornreich R; Liao J; Lorier R; Scott SA; Smith CH; Toji LH; Turner A; Kalman LV
J Mol Diagn; 2016 Jan; 18(1):109-23. PubMed ID: 26621101
[TBL] [Abstract][Full Text] [Related]
26. Characterization of ADME Gene Variation in Colombian Population by Exome Sequencing.
Silgado-Guzmán DF; Angulo-Aguado M; Morel A; Niño-Orrego MJ; Ruiz-Torres DA; Contreras Bravo NC; Restrepo CM; Ortega-Recalde O; Fonseca-Mendoza DJ
Front Pharmacol; 2022; 13():931531. PubMed ID: 35846994
[TBL] [Abstract][Full Text] [Related]
27. The Use of Next-Generation Sequencing in Pharmacogenomics.
Enko D; Michaelis S; Schneider C; Schaflinger E; Baranyi A; Schnedl WJ; Muller DJ
Clin Lab; 2023 Aug; 69(8):. PubMed ID: 37560847
[TBL] [Abstract][Full Text] [Related]
28. Development and Cross-Validation of High-Resolution Melting Analysis-Based Cardiovascular Pharmacogenetics Genotyping Panel.
Langaee T; El Rouby N; Stauffer L; Galloway C; Cavallari LH
Genet Test Mol Biomarkers; 2019 Mar; 23(3):209-214. PubMed ID: 30758238
[TBL] [Abstract][Full Text] [Related]
29. Targeted Next-Generation Sequencing for Comprehensive Genetic Profiling of Pharmacogenes.
Han SM; Park J; Lee JH; Lee SS; Kim H; Han H; Kim Y; Yi S; Cho JY; Jang IJ; Lee MG
Clin Pharmacol Ther; 2017 Mar; 101(3):396-405. PubMed ID: 27727443
[TBL] [Abstract][Full Text] [Related]
30. Clinical Relevance of a 16-Gene Pharmacogenetic Panel Test for Medication Management in a Cohort of 135 Patients.
Niedrig DF; Rahmany A; Heib K; Hatz KD; Ludin K; Burden AM; Béchir M; Serra A; Russmann S
J Clin Med; 2021 Jul; 10(15):. PubMed ID: 34361984
[TBL] [Abstract][Full Text] [Related]
31. A comprehensive Thai pharmacogenomics database (TPGxD-1): Phenotype prediction and variants identification in 942 whole-genome sequencing data.
John S; Klumsathian S; Own-Eium P; Eu-Ahsunthornwattana J; Sura T; Dejsuphong D; Sritara P; Vathesatogkit P; Thongchompoo N; Thabthimthong W; Teerakulkittipong N; Chantratita W; Sukasem C
Clin Transl Sci; 2024 Jun; 17(6):e13830. PubMed ID: 38853370
[TBL] [Abstract][Full Text] [Related]
32. Analyzing the clinical actionability of germline pharmacogenomic findings in oncology.
Wellmann R; Borden BA; Danahey K; Nanda R; Polite BN; Stadler WM; Ratain MJ; O'Donnell PH
Cancer; 2018 Jul; 124(14):3052-3065. PubMed ID: 29742281
[TBL] [Abstract][Full Text] [Related]
33. Pharmacogenomic profile of actionable molecular variants related to drugs commonly used in anesthesia: WES analysis reveals new mutations.
Parada-Márquez JF; Maldonado-Rodriguez ND; Triana-Fonseca P; Contreras-Bravo NC; Calderón-Ospina CA; Restrepo CM; Morel A; Ortega-Recalde OJ; Silgado-Guzmán DF; Angulo-Aguado M; Fonseca-Mendoza DJ
Front Pharmacol; 2023; 14():1047854. PubMed ID: 37021041
[No Abstract] [Full Text] [Related]
34. Current status of the analytical validation of next generation sequencing applications for pharmacogenetic profiling.
Huebner T; Steffens M; Scholl C
Mol Biol Rep; 2023 Nov; 50(11):9587-9599. PubMed ID: 37787843
[TBL] [Abstract][Full Text] [Related]
35. Clinical Utility of Pharmacogenomic Data Collected by a Health-System Biobank to Predict and Prevent Adverse Drug Events.
Shah SN; Gammal RS; Amato MG; Alobaidly M; Reyes DD; Hasan S; Seger DL; Krier JB; Bates DW
Drug Saf; 2021 May; 44(5):601-607. PubMed ID: 33620701
[TBL] [Abstract][Full Text] [Related]
36. Mapping the Pharmacogenetic Landscape in a Ugandan Population: Implications for Personalized Medicine in an Underrepresented Population.
Samarasinghe SR; Lee SB; Corpas M; Fatumo S; Guchelaar HJ; Nagaraj SH
Clin Pharmacol Ther; 2024 Jun; ():. PubMed ID: 38837390
[TBL] [Abstract][Full Text] [Related]
37. A review of pharmacogenetic studies in the Bangladeshi population.
Mostaid MS; Aziz MA; Maisha JA; Islam MS; Maruf AA
Drug Metab Pers Ther; 2023 Jun; 38(2):123-131. PubMed ID: 36854045
[TBL] [Abstract][Full Text] [Related]
38. Characterization of 107 genomic DNA reference materials for CYP2D6, CYP2C19, CYP2C9, VKORC1, and UGT1A1: a GeT-RM and Association for Molecular Pathology collaborative project.
Pratt VM; Zehnbauer B; Wilson JA; Baak R; Babic N; Bettinotti M; Buller A; Butz K; Campbell M; Civalier C; El-Badry A; Farkas DH; Lyon E; Mandal S; McKinney J; Muralidharan K; Noll L; Sander T; Shabbeer J; Smith C; Telatar M; Toji L; Vairavan A; Vance C; Weck KE; Wu AH; Yeo KT; Zeller M; Kalman L
J Mol Diagn; 2010 Nov; 12(6):835-46. PubMed ID: 20889555
[TBL] [Abstract][Full Text] [Related]
39. Integration of Germline Pharmacogenetics Into a Tumor Sequencing Program.
Hertz DL; Glatz A; Pasternak AL; Lonigro RJ; Vats P; Wu YM; Anderson B; Rabban E; Mora E; Frank K; Robinson DR; Mody RJ; Chinnaiyan A
JCO Precis Oncol; 2018; 2():. PubMed ID: 32832831
[TBL] [Abstract][Full Text] [Related]
40. Pharmacogenomics in Asians: Differences and similarities with other human populations.
Biswas M; Jinda P; Sukasem C
Expert Opin Drug Metab Toxicol; 2023 Jan; 19(1):27-41. PubMed ID: 36755439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
